B7-33 × 10 Vials

B7-33 is a synthetic peptide derived from the larger protein H2-relaxin (Relaxin). This peptide has been examined for its possible role in signaling pathways that may relate to fibrosis, tissue remodeling, and vascular processes. Research suggests that B7-33 may influence extracellular matrix regulation and interact with Relaxin-related receptors.

This peptide exibits potent anti-fibrotic effects. It is under active research and investigation as a means of reducing fibrosis in acute and chronic diseases like heart failure, lung inflammation, kidney and more. In animal studies, B7-33 has reduced fibrosis by roughly 50%, leading to prolonged survival following injury and offering the first new means of treating heart failure in 20 years. It has been shown to reduce excessive scar formation following cardiac injury. It has also shown promise in the treatment of certain vascular disorders as well as preeclampsia of pregnancy.

Molecular Formula: C131H228N40O37S
Molecular Weight:2987,75 g/mol
Other Known Titles: (B7-33)H2, GTPL9321